Insider Selling: Agilent Technologies, Inc. (NYSE:A) CEO Sells $274,120.00 in Stock

Agilent Technologies, Inc. (NYSE:A) CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $140.00, for a total transaction of $274,120.00. Following the sale, the chief executive officer now owns 26,076 shares of the company’s stock, valued at approximately $3,650,640. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Padraig Mcdonnell also recently made the following trade(s):

• On Monday, June 3rd, Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock. The stock was sold at an average price of $130.00, for a total transaction of $254,540.00.

Agilent Technologies Trading Up 1.0 %

Shares of A opened at $142.86 on Friday. The firm has a market cap of $41.68 billion, a price-to-earnings ratio of 33.77, a PEG ratio of 4.74 and a beta of 1.05. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $155.35. The firm has a 50 day moving average price of $133.55 and a 200-day moving average price of $137.81.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. The firm had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The business’s quarterly revenue was down 8.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.27 EPS. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd were issued a dividend of $0.236 per share. The ex-dividend date of this dividend was Tuesday, July 2nd. This represents a $0.94 dividend on an annualized basis and a yield of 0.66%. Agilent Technologies’s dividend payout ratio is currently 22.22%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on A shares. Jefferies Financial Group reiterated a “hold” rating and issued a $135.00 target price (down previously from $152.00) on shares of Agilent Technologies in a research note on Monday, June 3rd. Robert W. Baird reduced their target price on shares of Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating for the company in a research note on Thursday, May 30th. Bank of America boosted their price objective on shares of Agilent Technologies from $134.00 to $140.00 and gave the company a “neutral” rating in a research note on Tuesday, June 25th. Citigroup raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $135.00 to $150.00 in a research note on Wednesday, July 10th. Finally, Barclays reduced their price objective on shares of Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating for the company in a research note on Friday, May 31st. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $138.06.

Institutional Investors Weigh In On Agilent Technologies

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in A. Livelsberger Financial Advisory purchased a new position in Agilent Technologies during the 4th quarter valued at $26,000. Crewe Advisors LLC grew its position in shares of Agilent Technologies by 114.8% in the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after buying an additional 101 shares during the period. MV Capital Management Inc. grew its position in shares of Agilent Technologies by 120.7% in the 4th quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after buying an additional 105 shares during the period. VisionPoint Advisory Group LLC purchased a new stake in shares of Agilent Technologies in the 4th quarter worth about $29,000. Finally, Ridgewood Investments LLC purchased a new stake in shares of Agilent Technologies in the 2nd quarter worth about $29,000.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.